Phosphodiesterase inhibitors and the eye

Clinical and Experimental Ophthalmology

Volumn 37, Issue 5, 2009, Pages 514-523

  Kerr, Nathan M ^a   Danesh Meyer, Helen V ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Eye; Intraocular pressure; Optic nerve; Phosphodiesterase inhibitor; Retina; Stroke; Third nerve palsy

Indexed keywords

ERYTHROMYCIN; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL;

ANGINA PECTORIS; BRAIN HEMORRHAGE; CENTRAL SEROUS RETINOPATHY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLOR DISCRIMINATION; COLOR VISION DEFECT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG TOLERABILITY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MAXIMUM PLASMA CONCENTRATION; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; NOSE CONGESTION; OPHTHALMOPLEGIA; PHOTOSENSITIVITY; PLASMA HALF LIFE; PLASMA PROTEIN BINDING; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; RETINA BLOOD FLOW; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TEAR FILM; TRANSIENT ISCHEMIC ATTACK; VASCULAR SMOOTH MUSCLE; VEIN DIAMETER; VISUAL DISORDER;

CHOROID; COLOR VISION; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; HUMANS; INTRAOCULAR PRESSURE; OPTIC NEUROPATHY, ISCHEMIC; PHOSPHODIESTERASE INHIBITORS; REGIONAL BLOOD FLOW; RETINAL DETACHMENT; RETINAL VESSELS; VASODILATION; VISUAL ACUITY; VISUAL FIELDS;

EID: 67651161973     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02070.x     Document Type: Review

References (80)

1. Laties AM, Fraunfelder FT. Ocular safety of Viagra, (sildenafil citrate). Trans Am Ophthalmol Soc 1999; 97: 115-25.
2. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol 2006; 147: S252-7.
3. Beavo JA, Hardman JG, Sutherland EW. Hydrolysis of cyclic guanosine and adenosine 3′,5′-monophosphates by rat and bovine tissues. J Biol Chem 1970; 245: 5649-55.
4. Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A. Phosphodiesterase 5 inhibitors - drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des 2006; 12: 3459-65.
5. Hamet P, Coquil JF. Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets. J Cyclic Nucleotide Res 1978; 4: 281-90.
6. Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res 2004; 16: S11-14.
7. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-4.
8. Viagra [prescribing information]. Sandwich, Kent: Pfizer Limited, 2008.
9. Cialis [prescribing information]. Indianapolis, IN: Eli Lilly and Company, 2008.
10. Levitra [prescribing information]. Westhaven, CT: Bayer Healthcare, 2007.
11. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-404.
12. Strange J, Philllips S. Distribution of phosphodiesterase type 5 (PDE5) in normal and hypertensive human lung. Am J Respir Crit Care 2002; 165: A568.
13. Galie N, Ghofrani HA, Torbicki A et al., the Sildenafil Use in Pulmonary Arterial Hypertension Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-57.
14. Izbicki G, Rosengarten D, Picard E. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2006; 354: 1091-3.
15. Berkels R, Klotz T, Sticht G, Englemann U, Klaus W. Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. J Cardiovasc Pharmacol 2001; 37: 413-21.
16. Rosengarten B, Schermuly RT, Voswinckel R et al. Sildenafil improves dynamic vascular function in the brain: Studies in patients with pulmonary hypertension. Cerebrovasc Dis 2006; 21: 194-200.
17. Tawakol A, Aziz K, Migrino R et al. Effects of sildenafil on myocardial blood flow in humans with ischemic heart disease. Coron Artery Dis 2005; 16: 443-9.
18. Foresta C, Caretta N, Zuccarello D et al. Expression of the PDE5 enzyme on human retinal tissue: New aspects of PDE5 inhibitors ocular side effects. Eye 2008; 22: 144-9.
19. Marmor MF, Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 1999; 44: 153-62.
20. Paris G, Sponsel WE, Sandoval SS et al. Sildenafil increases ocular perfusion. Int Ophthalmol 2001; 23: 355-8.
21. Sponsel WE, Paris G, Sandoval SS et al. Sildenafil and ocular perfusion. N Engl J Med 2000; 342: 1680.
22. Grunwald JE, Siu KK, Jacob SS, Dupont J. Effect of sildenafil citrate (viagra) on the ocular circulation. Am J Ophthalmol 2001; 131: 751-5.
23. McCulley TJ, Luu JK, Marmor MF et al. Effects of sildenafil citrate (Viagra) on choroidal congestion. Ophthalmologica 2002; 216: 455-8.
24. Hayreh SS. Effect of sildenafil citrate (viagra) on the ocular circulation. Am J Ophthalmol 2002; 133: 169-70.
25. Dundar SO, Dayanir Y, Topaloǧl A, Dundar M, Kocak A. Effect of sildenafil on ocular hemodynamics in 3months regular use. Int J Impot Res 2006; 18: 282-6.
26. Dundar SO, Dundar M, Kocak I, Dayanir Y, Ozkan SB. Effect of sildenafil on ocular haemodynamics. Eye 2001; 15: 507-10.
27. Taner P, Basar MM, Unal B, Batislam E. Effects of vardenafil on intraocular pressure and orbital hemodynamics. J Ocul Pharmacol Ther 2007; 23: 275-9.
28. Koksal M, Ozdemir H, Kargi S et al. The effects of sildenafil on ocular blood flow. Acta Ophthalmol Scand 2005; 83: 355-9.
29. Yuan Z, Hein TW, Rosa RH Jr, Kuo L. Sildenafil (Viagra) evokes retinal arteriolar dilation: Dual pathways via NOS activation and phosphodiesterase inhibition. Invest Ophthalmol Vis Sci 2008; 49: 720-5.
30. Beavo JA. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48.
31. Birch DG, Toler SM, Swanson WH, Fish GE, Laties AM. A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration. Am J Ophthalmol 2002; 133: 665-72.
32. Center for Drug Evaluation and Research. Study 148-232: A randomised, double-blind, placebo-controlled, crossover pilot study to investigate the effects of a single oral tablet dose of sildenafil (200 mg) on visual function (electroretinogram, photostress, visual field and colour discrimination tests) in healthy male volunteers and patients with diabetic retinopathy. Viagra (Sildenafil):' Joint Clinical Review' for NDA-20-895. Washington, DC: Center for Drug Evaluation and Research, Food and Drug Administration, 1998; 177-8.
33. Center for Drug Evaluation and Research. Study 148-004: Phase I investigator-blind, placebo-controlled, evaluation of safety, toleration and pharmacokinetics of sildenafil following escalation single oral doses in healthy male volunteers. Viagra (Sildenafil): 'Joint Clinical Review' for NDA-20-895. Washington, DC: Center for Drug Evaluation and Research, Food and Drug Administration, 1998; 96-8.
34. Dundar SO, Topaloglu A, Dundar M, Kocak A. Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3months regular use. Eye 2006; 20: 810-13.
35. Ermis SS, Inan UU, Samli M et al. Acute effects of sildenafil on Humphrey visual field and intraocular pressure. Int Ophthalmol 2004; 25: 69-72.
36. McCulley TJ, Lam BL, Marmor MF, Hoffman KB, Luu JK, Feuer WJ. Acute effects of sildenafil (viagra) on blue-on-yellow and white-on-white Humphrey perimetry. J Neuroophthalmol 2000; 20: 227-8.
37. Oguz H, Verit A, Ozkul Y, Gurkan T, Ciftci H. No effects of long-term sildenafil treatment on ocular functions. Ann Ophthalmol 2005; 37: 85-90.
38. Oner HF, Aslan G, Kurtulan E, Ucar T, Saatci OA, Esen AA. Effect of sildenafil citrate on retinal functions: Preliminary report on Humphrey visual field analysis. Urol Int 2004; 73: 28-30.
39. Dundar M, Kocak I, Dundar SO, Erol H. Evaluation of side effects of sildenafil in group of young healthy volunteers. Int Urol Nephrol 2001; 32: 705-8.
40. Zrenner E, Koppiker N, Smith M. The effects of long-term sildenafil treatment on ocular safety in patients with erectile dysfunction. Invest Ophthalmol Vis Sci 2000; 41: S592.
41. Laties A, Ellis P, Mollon J. The effects of sildenafil citrate (VIAGRA) on colour discrimination in volunteers and patients with erectile dysfunction [Abstract]. Invest Ophthalmol Vis Sci 1999; 40 (Suppl.): 693S.
42. Jägle H, Jägle C, Sérey L et al. Visual short-term effects of viagra: Double-blind study in healthy young subjects. Am J Ophthalmol 2004; 137: 842-9.
43. Gabrieli CB, Regine F, Vingolo EM, Rispoli E, Fabbri A, Isidori A. Subjective visual halos after sildenafil (Viagra) administration: electroretinographic evaluation. Ophthalmology 2001; 108: 877-81.
44. Danesh-Meyer HV, Levin LA. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: Casual or causal association? Br J Ophthalmol 2007; 91: 1551-5.
45. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000; 98: 203-20, discussion 21-2.
46. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 1987; 94: 1503-8.
47. McLeod D, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol 1980; 64: 247-61.
48. Gorkin L, Hvidsten K, Sobel RE, Siegel R. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract 2006; 60: 500-3.
49. Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 1999; 83: 35C-44C.
50. Pache M, Meyer P, Prunte C, Orgul S, Nuttli I, Flammer J. Sildenafil induces retinal vasodilatation in healthy subjects. Br J Ophthalmol 2002; 86: 156-8.
51. Hotta H, Ito H, Kagitani F, Sato A. Cilostazol, a selective cAMP phosphodiesterase inhibitor, dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Eur J Pharmacol 1998; 344: 49-52.
52. Grunwald JE, Metelitsina T, Grunwald L. Effect of sildenafil citrate (Viagra) on retinal blood vessel diameter. Am J Ophthalmol 2002; 133: 809-12.
53. Polak K, Wimpissinger B, Berisha F, Georgopoulos M, Schmetterer L. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Invest Ophthalmol Vis Sci 2003; 44: 4872-6.
54. Metelitsina TI, Grunwald JE, DuPont JC, Ying G-S, Liu C. Effect of viagra on retinal vein diameter in AMD patients. Exp Eye Res 2006; 83: 128-32.
55. Farber DB, Lolley RN. Cyclic guanosine monophosphate: Elevation in degenerating photoreceptor cells of the C3H mouse retina. Science 1974; 186: 449-51.
56. Danciger M, Blaney J, Gao YQ et al. Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa. Genomics 1995; 30: 1-7.
57. Wallis RM, Leishman D, Pullman L, Graepel P, Heywood R. Effects of sildenafil on retinal histopathology and electroretinogram (ERG) in dogs. Ophthalmic Res 1998; 30 (Suppl. 1): S68.
58. Vatansever HS, Kayikcioglu O, Gumus B. Histopathologic effect of chronic use of sildenafil citrate on the choroid & retina in male rats. Indian J Med Res 2003; 117: 211-15.
59. Lüke M, Lüke C, Hescheler J Jr, Schneider T, Sickel W. Effects of phosphodiesterase type 5 inhibitor sildenafil on retinal function in isolated superfused retina. J Ocul Pharmacol Ther 2005; 21: 305-14.
60. Vobig MA, Klotz T, Staak M, Bartz-Schmidt KU, Engelmann U, Walter P. Retinal side-effects of sildenafil. Lancet 1999; 353: 375.
61. Luu JK, Chappelow AV, McCulley TJ, Marmor MF. Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 2001; 132: 388-94.
62. Lüke M, Szurman P, Schneider T, Lüke C. The effects of the phosphodiesterase type V inhibitor sildenafil on human and bovine retinal function in vitro. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1211-15.
63. Nawy S, Jahr CE. Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature 1990; 346: 269-71.
64. Becker B. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits. Invest Ophthalmol Vis Sci 1990; 31: 1647-9.
65. Kee C, Kaufman PL, Gabelt BT. Effect of 8-Br cGMP on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci 1994; 35: 2769-73.
66. Yajima T, Yajima Y, Koppiker N, Grunwald JE, Laties AM. No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra). Am J Ophthalmol 2000; 129: 675-6.
67. Grunwald JE, Jacob SS, Siu K, Piltz J, Dupont J. Acute effects of sildenafil citrate (Viagra®) on intraocular pressure in open-angle glaucoma. Am J Ophthalmol 2001; 132: 872-4.
68. Acaroglu G, Akinci A, Zilelioĝlu O. Sildenafil associated pupil-sparing third nerve palsy. Neuroophthalmology 2006; 30: 117-19.
69. Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol 1998; 126: 476-7.
70. Buxton N, Flannery T, Wild D, Bassi S. Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage. Br J Neurosurg 2001; 15: 347-9.
71. Morgan JCMDP, Alhatou MMD, Oberlies JMD, Johnston KCMD. Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology 2003; 57: 1730-1
72. Monastero R, Pipia C, Camarda LK, Camarda R. Intracerebral haemorrhage associated with sildenafil citrate. J Neurol 2001; 248: 141-2.
73. McGee HT, Egan RA, Clark WM, McGee HT, Egan RA, Clark WM. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 2005; 64: 1095-6.
74. Lundberg PO, Osterman PO. The benign and malignant forms of orgasmic cephalgia. Headache 1974; 14: 164-5.
75. Hellstrom WJ, Hellstrom WJG. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 2006; 66: 293-4.
76. Quiram P, Dumars S, Parwar B et al. Viagra-associated serous macular detachment. Graefes Arch Clin Exp Ophthalmol 2005; 243: 339-44.
77. Allibhai ZA, Gale JS, Sheidow TS, Allibhai ZA, Gale JS, Sheidow TS. Central serous chorioretinopathy in a patient taking sildenafil citrate. Ophthalmic Surg Lasers Imaging 2004; 35: 165-7.
78. Oguz H, Verit A, Gurkan T, Yeni E. The acute effects of sildenafil on tear functions. Ann Ophthalmol 2005; 37: 281-4.
79. Sullivan DA, Wickham LA, Rocha EM et al. Androgens and dry eye in Sjogren's syndrome. Ann N Y Acad Sci 1999; 876: 312-24.
80. Verit A, Oguz H. Ophthalmic aspects of erectile dysfunction drugs. Am J Ophthalmol 2006; 141: 598.